Idiopathic hypereosinophilic syndrome in children: Report of a 7-year-old boy with FIP1L1-PDGFRA rearrangement

Journal of Pediatric Hematology/Oncology

Volumn 27, Issue 12, 2005, Pages 663-665

  Rives, Susana ^a,c   Alcorta, Iñaki ^a   Toll, Teresa ^a   Tuset, Esperanza ^a   Estella, Jesús ^a   Cross, Nicholas C P ^b  

^a HOSPITAL SANT JOAN DE DÉU   (Spain)

^b SALISBURY DISTRICT HOSPITAL   (United Kingdom)

^c HOSPITAL SANT JOAN DE DÉU   (Spain)

Author keywords

Children; Chronic eosinophilic leukemia; FIP1L1 PDGFRA; Gleich syndrome; Hypereosinophilic syndrome; Imatinib

Indexed keywords

IMATINIB; PREDNISONE;

ADOLESCENT; ARTICLE; CASE REPORT; CHROMOSOME REARRANGEMENT; CLINICAL FEATURE; DISEASE COURSE; FEMALE; FUSION GENE; HUMAN; HYPEREOSINOPHILIC SYNDROME; IDIOPATHIC DISEASE; KARYOTYPING; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RELAPSE; SCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS; CHILD; FEMALE; HUMANS; HYPEREOSINOPHILIC SYNDROME; MALE; MRNA CLEAVAGE AND POLYADENYLATION FACTORS; ONCOGENE PROTEINS, FUSION; PREDNISONE; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; RECURRENCE;

EID: 29144524525     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/01.mph.0000193467.06938.77     Document Type: Article

References (15)

1. Jaffe ES, Harris NL, Stein H, et al, eds. World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon, France: International Agency for Research on Cancer (IARC) Press, 2001.
2. Cools J, DeAngelo DJ, Gotlib J, et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med. 2003;348:1201-1214.
3. Katz HT, Haque SJ, Hsieh FH. Pediatric hypereosinophilic syndrome (HES) differs from adult HES. J Pediatr. 2005;146:134-136.
4. Simon HU, Plötz SG, Dummer R, et al. Abnormal clones of interleukin-5-producing T cells in idiopathic eosinophilia. N Engl J Med. 1999;341:1112-1120.
5. Roche-Lestienne C, Lepers S, Soenen-Cornu V, et al. Molecular characterization of the idiopathic hypereosinophilic syndrome (HES) in 35 French patients with normal conventional cytogenetics. Leukemia. 2005;19:792-798.
6. Alfaham MA, Ferguson SD, Sihra B, et al. The idiopathic hypereosinophilic syndrome. Arch Dis Child. 1987;62:601-613.
7. Wynn SR, Sachs MI, Keating MU, et al. Idiopathic hypereosinophilic syndrome in a 5 1/2-month-old infant. J Pediatr. 1987;111:94-97.
8. Leblond P, Lepers S, Thebaud E, et al. Le syndrome d'hyperé osinophilie essentielle: à propos d'un cas chez un nourrisson. Arch Pediatr. 2004;11:219-222.
9. Baratta L, Afeltra A, Delfino M, et al. Favorable response to high-dose interferon-alpha in idiopathic hypereosinophilic syndrome with restrictive cardiomyopathy. Case report and literature review. Angiology. 2002;53:465-470.
10. Rose C, Dupire S, Roche-Lestienne C, et al. Sustained molecular response with imatinib in a leukemic form of idiopathic hypereosinophilic syndrome in relapse after allograft. Leukemia. 2004;18:354-355.
11. Malagola M, Martinelli G, Rondoni M, et al. Soft tissue and skeletal involvement in FIP1L1-PDGFR-α positive chronic eosinophilic leukemia: imatinib mesylate may induce complete molecular and imaging remission. Haematologica. 2004;89:ECR25.
12. Chusid MJ, Dale DC, West BC, et al. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Balt). 1975;54:1-27.
13. Lefebvre C, Bletry O, Degoulet P, et al. Facteurs pronostiques du syndrome hypereosinophilique. Étude de 40 observations. Ann Med Interne (Paris). 1989;140:253-257.
14. Scheinfeld N. Fatal fulminant hypereosinophilic syndrome with a petechial rash in a 16-year-old girl. J Pediatr Hematol Oncol. 2003;25:827-830.
15. Gleich GJ, Schroeter AL, Marcoux P, et al. Episodic angioedema associated with eosinophilia. N Engl J Med. 1984;310:1621-1626.